Awiqli, the world's first once-a-week basal insulin, has been launched in India, reducing insulin injections from 365 to 52 a ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

Danish drugmaker Novo Nordisk, launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete ...

Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.

Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes rates ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

A Michigan agency that licenses adult foster care homes doesn't require deaths to be reported and only investigates if ...

Novo Nordisk has launched Awiqli, a once-weekly basal insulin, in India. This innovation offers a significant reduction from ...

India: Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with type 1 and type 2 diabetes, has been ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...